Homocystinuria is a rare genetic condition. It affects how the body processes an amino acid called methionine. This leads to high levels of homocysteine in the blood and urine. It can cause problems with the skeleton, muscles, eyes, and blood vessels, increasing the risk of heart attacks and strokes.
Every report comes from a Lived member, sent anonymously.
Have you tried Vitamin B6 for Homocystinuria?
Homocystinuria is an inherited condition in which the body cannot process methionine, an amino acid found in protein, in the usual way. In the most common form, called classical homocystinuria, an enzyme named cystathionine beta-synthase (CBS) does not work properly, so the condition is also called CBS deficiency. A related substance, homocysteine, then builds up in the blood, and some of it passes into the urine, which is where the name comes from. Over time, high homocysteine affects four main parts of the body: the eyes, the skeleton, the brain and the blood vessels. Typical problems include a lens in the eye that slips out of place and severe nearsightedness, a tall, slender build with long limbs, thin and fragile bones (osteoporosis), learning difficulties, and a tendency to form blood clots. Severity varies widely. Some people become ill in childhood, while others have few or no symptoms until a blood clot in adulthood leads to the diagnosis. Because the eye problems and body build can resemble Marfan syndrome, the two conditions are sometimes confused.
Classical homocystinuria is caused by changes (variants) in the CBS gene and is inherited in an autosomal recessive pattern. A person has the condition only when both copies of the gene, one from each parent, are affected. Parents who each carry one changed copy usually have no symptoms. The condition occurs worldwide but is more common in some populations, such as in Qatar, where marriage between relatives is common, and in Ireland and Norway. The specific gene change strongly shapes how severe the condition is, largely through whether it responds to vitamin B6 (pyridoxine). People whose homocysteine falls with vitamin B6 generally have a milder course that starts later in life. Rarer forms of homocystinuria come from other genes involved in recycling homocysteine; they behave differently and are treated differently. For someone who has the condition, the chance of a blood clot is highest when homocysteine is poorly controlled. Dehydration and long periods without moving raise that risk further.
The key test is a blood test for total homocysteine. In untreated classical homocystinuria, the level is usually above 100 micromoles per liter (μmol/L), though it can be lower in milder cases. Mildly raised homocysteine is much more common and has other causes, including low levels of vitamin B12 (cobalamin), kidney problems and some medicines, so a high result is followed by more tests. A high methionine level alongside high homocysteine points toward CBS deficiency. The diagnosis is then confirmed by genetic testing of the CBS gene or by measuring the enzyme's activity; sometimes both are needed because each can miss cases. Many babies are now found through newborn screening, which looks for high methionine in the heel-prick blood sample. Screening can miss cases, particularly the milder vitamin B6 responsive form, so a normal newborn screen does not rule homocystinuria out. Testing is worth considering in anyone with a dislocated lens, an unexplained blood clot, or a Marfan-like build with learning difficulties. Once one person in a family is diagnosed, brothers and sisters should be tested too, since they can be affected without symptoms.
Treatment aims to keep homocysteine low for life while allowing normal growth and nutrition. The target depends on the form. People who respond to vitamin B6 aim for a total homocysteine below 50 μmol/L, though this may not be reachable for those who respond only partly. For people who do not respond, complications appear to be unlikely when levels stay below about 120 μmol/L, and because levels fluctuate, the international guideline recommends keeping them below 100. That guideline also notes that the evidence behind its recommendations is limited, as it often is for rare diseases. The first step is usually a trial of vitamin B6, which helps the faulty enzyme work in some people. About half respond to some degree. Those who respond well may need little more than the vitamin and a folate supplement. Very high doses of vitamin B6 taken over a long period can damage nerves, so the dose is kept to the lowest that reaches the target. People who do not respond fully usually need a diet very low in natural protein, which limits methionine, combined with a prescribed medical formula that supplies the other amino acids the body needs. The diet is demanding, and it is easier to keep when started in infancy with an experienced metabolic dietitian. Betaine (Cystadane) is a prescription powder taken by mouth that lowers homocysteine by converting it back into methionine. It is often added when diet alone is not enough or is hard to sustain. Because betaine can push methionine too high, methionine levels are monitored; very high methionine has been linked to brain swelling. Folate is given to everyone, and vitamin B12 is checked and replaced if low. Treatment prevents new complications but does not reverse ones already present, such as a dislocated lens or bone changes. These may need eye or orthopedic surgery, with extra precautions against clots. People who have already had a clot, or whose levels are hard to control, may also take a blood thinner or an antiplatelet medicine such as aspirin.
When treatment starts soon after birth and is kept up, outcomes are generally good. In groups of children found by newborn screening who maintained good control, complications were largely prevented and intelligence was in the normal range, and the aim is for people to study, work and have families. Very long-term outcomes are still being studied. For people diagnosed later, treatment focuses on preventing further problems, especially clots, and some see improvements in behavior or seizures. Daily life revolves around the treatment routine: vitamins or betaine every day, and for many people a carefully measured diet and formula. Regular blood tests check homocysteine and methionine, and the metabolic team adjusts the plan as needs change. Bone density scans are recommended from adolescence, along with regular eye checks. Keeping up treatment is often hardest in the teenage and young adult years, and losing control at any age can lead to serious, sometimes life-threatening complications. Some situations need planning with the care team in advance. Surgery and anesthesia raise clot risk, and the anesthesia team should avoid nitrous oxide (laughing gas), which raises homocysteine. Long trips call for staying active and well hydrated. Estrogen-containing birth control is generally avoided because it adds to the risk of clots. Pregnancy is possible, but it needs close metabolic monitoring and usually preventive blood-thinner injections in late pregnancy and for at least six weeks after delivery, when clot risk is highest. Depression and other mental health difficulties are more common in homocystinuria and are worth raising with the care team.
Ask about testing if you or your child has a dislocated lens, rapidly worsening nearsightedness or an unexplained blood clot, or if a brother or sister has been diagnosed. If you already have the diagnosis, contact the metabolic team before planned surgery, when planning a pregnancy, and when an illness causes vomiting or makes it hard to drink and keep taking treatment. Get same-day medical care for pain, swelling, warmth or redness in one leg or arm, which can signal a clot in a deep vein. Severe eye pain or a sudden loss of vision needs immediate medical help, because a displaced lens can block fluid drainage and raise pressure inside the eye. Call 911 for sudden shortness of breath, chest pain or coughing up blood, which can signal a clot in the lungs. Also call 911 for sudden numbness or weakness on one side of the body, sudden confusion or trouble speaking, or a sudden severe headache, which can signal a clot in the brain.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Homocystinuria is like, what's helped you, or ask the community a question.